Amélie Vézina

发表

Isotope-labeled differential profiling of metabolites using N-benzoyloxysuccinimide derivatization coupled to liquid chromatography/high-resolution tandem mass spectrometry.

B. Annabi, R. Roy, M. Wagner, 2015, Rapid communications in mass spectrometry : RCM.

Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent

R. Béliveau, B. Annabi, Amélie Vézina, 2012, Drug target insights.

EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells

B. Annabi, Amélie Vézina, Rima Chokor, 2012, Cancer Immunology, Immunotherapy.

Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism

B. Annabi, Cyndia Charfi, Alain Zgheib, 2018, Molecular Neurobiology.

Model systems for studying the blood-brain barrier: Applications and challenges.

M. Gottesman, R. Robey, K. Tanner, 2019, Biomaterials.

Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.

D. Maric, J. Heiss, B. Kaur, 2020, Neuro-oncology.

Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-α and requires NF-κB signaling.

B. Annabi, Amélie Vézina, Éric Vaillancourt-Jean, 2014, Cancer letters.

Adenosine A2A Receptor Activation Enhances Blood–Tumor Barrier Permeability in a Rodent Glioma Model

K. Nagashima, M. Gilbert, Wei Zhang, 2021, Molecular Cancer Research.

Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.

D. Maric, B. Kaur, J. Yoo, 2020, Neuro-oncology.